Search Results 661-670 of 17044 for monoclonal antibody

  1. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

    ... monoclonal antibody (bevacizumab, ramucirumab, or aflibercept), and an anti-PD-1 monoclonal antibody (nivolumab or pembrolizumab) if tumor has deficient ...

  2. Nirsevimab-alip (intramuscular route) - Side effects & uses - Mayo Clinic

    This medicine works by giving your body antibodies to protect it against RSV infection. RSV infection can cause serious problems that affect the lungs, such ...

  3. Publications - Niloufar Yarandi, M.D. - Mayo Clinic

    Heavy Chain/Light Chain Antibody Immunofluorescence to Identify Monoclonal Plasma Cells in a Case of Plasma Cell-Rich Acute Interstitial Nephritis. Kidney ...

  4. Cancer Treatment Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. ... The biomarker and antibody results along with your personal ...

  5. Mayo Clinic Alzheimer's Disease Research Center Archives

    ... monoclonal antibody, lecanemab shows promise in removing amyloid plaques from the brain. Plaques are one of the defining features of Alzheimer's disease. Dr ...

  6. PR3-AAV Resilient Remission or PRRR - Mayo Clinic

    ... Antibody (ANCA) at 6 months. The study is a double ... - History of intolerance to rituximab or other chimeric monoclonal antibodies (e.g., infliximab).

  7. COVID19 Immunology and Omics Study - Clinical Trials

    Individuals who are recieving a monoclonal antibody infusion. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  8. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody (eg.daratumumab or isatuximab) - Prior non-belantamab mafodotin anti-BCMA agent exposure is allowed; patients with prior treatment with ...

  9. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    -History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins) -Patient with history ...

  10. Publications - Michael A. Edwards, M.D. - Mayo Clinic

    Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody ...